Altered sirtuin expression is associated with node-positive breast cancer

被引:198
作者
Ashraf, N.
Zino, S.
MacIntyre, A.
Kingsmore, D.
Payne, A. P.
George, W. D.
Shiels, P. G.
机构
[1] Univ Glasgow, Western Infirm, Dept Surg, Div Canc Sci & Mol Pathol, Glasgow G11 6NT, Lanark, Scotland
[2] Western Infirm & Associated Hosp, Renal Transplant Unit, Glasgow, Lanark, Scotland
[3] Univ Glasgow, IBLS, Glasgow, Lanark, Scotland
关键词
breast cancer; sirtuins; gene expression;
D O I
10.1038/sj.bjc.6603384
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Sirtuins are genes implicated in cellular and organismal ageing. Consequently, they are speculated to be involved in diseases of ageing including cancer. Various cancers with widely differing prognosis have been shown to have differing and characteristic expression of these genes; however, the relationship between sirtuin expression and cancer progression is unclear. In order to correlate cancer progression and sirtuin expression, we have assessed sirtuin expression as a function of primary cell ageing and compared sirtuin expression in normal, 'nonmalignant' breast biopsies to breast cancer biopsies using real-time polymerase chain reaction (PCR). Levels of SIRT7 expression were significantly increased in breast cancer (P < 0.0001). Increased levels of SIRT3 and SIRT7 transcription were also associated with node-positive breast cancer (P < 0.05 and P < 0.0001, respectively). This study has demonstrated differential sirtuin expression between nonmalignant and malignant breast tissue, with consequent diagnostic and therapeutic implications.
引用
收藏
页码:1056 / 1061
页数:6
相关论文
共 25 条
  • [1] TP53 and breast cancer
    Borresen-Dale, AL
    [J]. HUMAN MUTATION, 2003, 21 (03) : 292 - 300
  • [2] THE SIR2 GENE FAMILY, CONSERVED FROM BACTERIA TO HUMANS, FUNCTIONS IN SILENCING, CELL-CYCLE PROGRESSION, AND CHROMOSOME STABILITY
    BRACHMANN, CB
    SHERMAN, JM
    DEVINE, SE
    CAMERON, EE
    PILLUS, L
    BOEKE, JD
    [J]. GENES & DEVELOPMENT, 1995, 9 (23) : 2888 - 2902
  • [3] *CANC STATS, 2005, CANC RES UK
  • [4] Isolation of a SIR-like gene, SIR-T8, that is overexpressed in thyroid carcinoma cell lines and tissues
    de Nigris, F
    Cerutti, J
    Morelli, C
    Califano, D
    Chiariotti, L
    Viglietto, G
    Santelli, G
    Fusco, A
    [J]. BRITISH JOURNAL OF CANCER, 2002, 86 (06) : 917 - 923
  • [5] A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO
    DIMRI, GP
    LEE, XH
    BASILE, G
    ACOSTA, M
    SCOTT, C
    ROSKELLEY, C
    MEDRANO, EE
    LINSKENS, M
    RUBELJ, I
    PEREIRASMITH, O
    PEACOCKE, M
    CAMPISI, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) : 9363 - 9367
  • [6] Role for human SIRT2 NAD-dependent deacetylase activity in control of mitotic exit in the cell cycle
    Dryden, SC
    Nahhas, FA
    Nowak, JE
    Goustin, AS
    Tainsky, MA
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (09) : 3173 - 3185
  • [7] Mammalian Sir2 homolog SIRT7 is an activator of RNA polymerase I transcription
    Ford, E
    Voit, R
    Liszt, G
    Magin, C
    GrumMt, I
    Guarente, L
    [J]. GENES & DEVELOPMENT, 2006, 20 (09) : 1075 - 1080
  • [8] 'SIRT8' expressed in thyroid cancer is actually SIRT7
    Frye, R
    [J]. BRITISH JOURNAL OF CANCER, 2002, 87 (12) : 1479 - 1479
  • [9] Phylogenetic classification of prokaryotic and eukaryotic Sir2-like proteins
    Frye, RA
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 273 (02) : 793 - 798
  • [10] THE NOTTINGHAM PROGNOSTIC INDEX IN PRIMARY BREAST-CANCER
    GALEA, MH
    BLAMEY, RW
    ELSTON, CE
    ELLIS, IO
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 1992, 22 (03) : 207 - 219